THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Mohamad Khawandanah

Concepts (88)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Follicular
1
2018
13
0.580
Why?
Antibodies
1
2018
124
0.550
Why?
Antibodies, Monoclonal
1
2018
329
0.500
Why?
Intrauterine Devices, Medicated
1
2014
3
0.460
Why?
Polyethylene
1
2014
12
0.460
Why?
Cryoprotective Agents
1
2014
4
0.460
Why?
Anemia, Hemolytic, Autoimmune
1
2014
8
0.460
Why?
Dimethyl Sulfoxide
1
2014
11
0.460
Why?
Bone Marrow Transplantation
1
2014
49
0.450
Why?
Anus Neoplasms
1
2014
5
0.440
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2014
41
0.440
Why?
Polyethylene Glycols
1
2014
100
0.430
Why?
Thrombocytopenia
1
2014
113
0.410
Why?
Myocardial Infarction
1
2014
346
0.370
Why?
Neoplasm Recurrence, Local
1
2014
330
0.360
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
411
0.330
Why?
Hematopoietic Stem Cell Transplantation
2
2022
82
0.320
Why?
Cord Blood Stem Cell Transplantation
1
2022
7
0.200
Why?
Purpura, Thrombotic Thrombocytopenic
2
2023
216
0.200
Why?
Graft vs Host Disease
1
2022
29
0.200
Why?
Lymphoma, Large B-Cell, Diffuse
1
2023
28
0.200
Why?
Purpura, Thrombocytopenic, Idiopathic
1
2023
94
0.190
Why?
Thrombosis
1
2023
149
0.180
Why?
Humans
11
2023
28121
0.180
Why?
Adult
6
2023
7757
0.160
Why?
Male
6
2023
13487
0.160
Why?
Intracranial Embolism
1
2019
6
0.160
Why?
Cerebral Cortex
1
2019
134
0.150
Why?
Female
7
2023
15156
0.140
Why?
Lymphoma
1
2017
26
0.140
Why?
Stroke
1
2019
252
0.120
Why?
Agglutination Tests
1
2014
8
0.120
Why?
Alemtuzumab
1
2014
4
0.120
Why?
Polycythemia Vera
1
2014
14
0.120
Why?
Levonorgestrel
1
2014
5
0.120
Why?
Glucosephosphate Dehydrogenase Deficiency
1
2014
1
0.120
Why?
Quinazolines
1
2014
32
0.110
Why?
Mice, SCID
1
2014
61
0.110
Why?
Mice, Inbred NOD
1
2014
49
0.110
Why?
Cryopreservation
1
2014
13
0.110
Why?
Janus Kinase 2
1
2014
36
0.110
Why?
Transplantation, Homologous
1
2014
47
0.110
Why?
Device Removal
1
2014
30
0.110
Why?
Splenectomy
1
2014
44
0.110
Why?
Drug Resistance
1
2014
42
0.110
Why?
Ifosfamide
1
2014
9
0.110
Why?
Mitomycin
1
2014
19
0.110
Why?
Cetuximab
1
2014
21
0.110
Why?
Bone Marrow Cells
1
2014
80
0.110
Why?
Plasma Exchange
1
2014
104
0.110
Why?
Blood Transfusion
1
2014
77
0.110
Why?
Combined Modality Therapy
1
2014
302
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2014
144
0.110
Why?
Immunosuppressive Agents
1
2014
148
0.100
Why?
Cisplatin
1
2014
179
0.100
Why?
Paclitaxel
1
2014
190
0.100
Why?
Middle Aged
4
2023
7164
0.100
Why?
Animals
2
2018
10399
0.100
Why?
Carcinoma, Squamous Cell
1
2014
164
0.100
Why?
Adolescent
3
2023
3123
0.080
Why?
Antineoplastic Agents
1
2014
678
0.080
Why?
Mice
1
2014
4645
0.060
Why?
Aged
3
2023
5416
0.060
Why?
SEER Program
1
2023
47
0.050
Why?
Focus Groups
1
2023
95
0.050
Why?
Graft Survival
1
2022
29
0.050
Why?
Minority Groups
1
2023
70
0.050
Why?
Activities of Daily Living
1
2023
109
0.050
Why?
Cell- and Tissue-Based Therapy
1
2022
14
0.050
Why?
Tertiary Care Centers
1
2022
27
0.050
Why?
Immunotherapy, Adoptive
1
2022
17
0.050
Why?
Outpatients
1
2022
44
0.050
Why?
Receptors, Antigen, T-Cell
1
2022
77
0.050
Why?
Feasibility Studies
1
2022
193
0.050
Why?
Warfarin
1
2019
94
0.040
Why?
Autografts
1
2017
3
0.040
Why?
Aged, 80 and over
1
2023
2021
0.040
Why?
Disease-Free Survival
1
2017
238
0.030
Why?
Risk Factors
1
2022
2084
0.030
Why?
Survival Rate
1
2017
430
0.030
Why?
Retrospective Studies
1
2022
2557
0.030
Why?
Young Adult
1
2023
2731
0.030
Why?
Erlotinib Hydrochloride
1
2014
10
0.030
Why?
Valine
1
2014
12
0.030
Why?
Phenylalanine
1
2014
24
0.030
Why?
Amino Acid Substitution
1
2014
103
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2014
67
0.030
Why?
Treatment Outcome
1
2014
2380
0.020
Why?
Khawandanah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (88)
Explore
_
Co-Authors (22)
Explore
_
Similar People (57)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES